Prosecution Insights
Last updated: November 12, 2026
Application No. 19/082,030

LIGHT-BASED VAGINAL THERAPY DEVICES AND METHODS FOR USE

Non-Final OA §DOUBLEPATENT
Filed
Mar 17, 2025
Priority
Jul 03, 2014 — provisional 62/020,874 +5 more
Examiner
LUAN, SCOTT
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cern Corp.
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
77%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
437 granted / 666 resolved
-4.4% vs TC avg
Moderate +12% lift
Without
With
+11.6%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
43 currently pending
Career history
712
Total Applications
across all art units

Office Action

§DOUBLEPATENT
DETAILED ACTION Status of Claims The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 21-46 are pending. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 21- 46 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-31 of U.S. Patent No. US 12251570 B2 and claims 1-30 of U.S. Patent No. US 11931595 B2. Although the language of the claims at issue are not identical, the claims are not patentably distinct from each other because they are directed to the same invention. Allowable Subject Matter Claims 21-46 are allowed, contingent on Applicant’s filing of a Terminal Disclaimer, as discussed above. The prior art of record does not teach or suggest the claimed invention of a method for vaginal light therapy of a patient, comprising: providing a treatment device comprising a body having an outer surface extending between a proximal end and a rounded distal end of the body; applying an agent into one or more pockets or features in the outer surface of the body (as recited in claim 21); a device for vaginal light therapy of a patient, comprising: a body having an outer surface extending between a proximal end and a rounded distal end of the body and a plurality of depressions or pockets in the outer surface configured to receive an agent applied to the outer surface (as recited in claim 41). The closest prior art reference is Mayer (US 20090319008 Al, December 24, 2009). Mayer teaches a method for vaginal light therapy of a patient, comprising providing, inserting, and removing a phototherapeutic treatment device comprising a body having an outer surface extending between a proximal end and a rounded distal end of the body. But Mayer does not teach applying a photosensitizing agent into one or more pockets or features in the outer surface of the body. For these reasons the claims are believed to be allowable over the art of record. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SCOTT T LUAN whose telephone number is (571)270-1860. The examiner can normally be reached on 9am-5pm, M-F (generally). If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Gary Jackson, can be reached on 571-272-4697. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Scott Luan /SCOTT LUAN/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Mar 17, 2025
Application Filed
Oct 22, 2026
Non-Final Rejection mailed — §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788514
MASTER WORKSTATION FOR ROBOTIC SURGERY, STERILE OPERATORY FIELD, SURGICAL ROBOTIC SYSTEM AND METHOD
4y 3m to grant Granted Nov 10, 2026
Patent 12788388
SURGICAL SYSTEMS AND INSTRUMENTS WITH ENHANCED CLEANABILITY
2y 11m to grant Granted Nov 10, 2026
Patent 12779201
CANNULA FOR INTRAVASCULAR BLOOD PUMP
3y 3m to grant Granted Nov 03, 2026
Patent 12779231
DEVICES, SYSTEMS AND METHODS THAT SELECT ELECTRODE VECTOR FOR CONDUCTIVE COMMUNICATION BETWEEN EXTERNAL DEVICE AND IMPLANTABLE MEDICAL DEVICES
1y 8m to grant Granted Nov 03, 2026
Patent 12773266
Apparatus and Method for Reducing Laser Beam Attenuation in a Liquid Medium
2y 9m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
77%
With Interview (+11.6%)
Low
PTA Risk
Based on 666 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month